Add to ORKGNew drugs for acute and chronic Hepatitis B Virus (HBV) infection: from HBV-entry inhibition to liver-specific drug targetting Urban, StephanNext generation sequencing offers new perspectives in comparative genomics of plant associated bacteria Kube, Michae
A major unmet clinical need is a therapeutic capable of removing hepatitis B virus (HBV) genome from...
International audienceCurrent treatments against chronic hepatitis B (CHB) include pegylated interfe...
Chronic hepatitis B (CHB) is a highly complicated pathological process in which the disease is initi...
Currently approved treatments for hepatitis B virus (HBV) infection include the immunomodulatory age...
Globally, chronic hepatitis B (CHB) infection is one of the leading causes of liver failure, decompe...
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Chronic hepatitis B virus (HB...
Current antiviral therapies have dramatically improved the long-term outcomes of patients with chron...
The major pandemics caused by chronic viral infections is produced by HIV, hepatitis C virus (HCV), ...
Current treatments for chronic hepatitis B are able to provide a sustained suppression of the viral ...
Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million...
Since the discovery of the hepatitis B virus (HBV) by Blumberg et al., nearly half a century ago, th...
Hepatitis B virus vaccination, while effective in reducing incident chronic hepatitis B in endemic r...
With the advent of various vaccines and antimicrobial agents during the 20th century, the control an...
Abstract Background Hepatitis B virus (HBV) chronic infection affects up to 240 million people in th...
Introduction: Current treatment options for chronic hepatitis B virus (HBV) infection cannot achieve...
A major unmet clinical need is a therapeutic capable of removing hepatitis B virus (HBV) genome from...
International audienceCurrent treatments against chronic hepatitis B (CHB) include pegylated interfe...
Chronic hepatitis B (CHB) is a highly complicated pathological process in which the disease is initi...
Currently approved treatments for hepatitis B virus (HBV) infection include the immunomodulatory age...
Globally, chronic hepatitis B (CHB) infection is one of the leading causes of liver failure, decompe...
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Chronic hepatitis B virus (HB...
Current antiviral therapies have dramatically improved the long-term outcomes of patients with chron...
The major pandemics caused by chronic viral infections is produced by HIV, hepatitis C virus (HCV), ...
Current treatments for chronic hepatitis B are able to provide a sustained suppression of the viral ...
Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million...
Since the discovery of the hepatitis B virus (HBV) by Blumberg et al., nearly half a century ago, th...
Hepatitis B virus vaccination, while effective in reducing incident chronic hepatitis B in endemic r...
With the advent of various vaccines and antimicrobial agents during the 20th century, the control an...
Abstract Background Hepatitis B virus (HBV) chronic infection affects up to 240 million people in th...
Introduction: Current treatment options for chronic hepatitis B virus (HBV) infection cannot achieve...
A major unmet clinical need is a therapeutic capable of removing hepatitis B virus (HBV) genome from...
International audienceCurrent treatments against chronic hepatitis B (CHB) include pegylated interfe...
Chronic hepatitis B (CHB) is a highly complicated pathological process in which the disease is initi...